Prospective precision medicine trial of crizotinib (C) in patients (pts) with advanced, inoperable inflammatory myofibroblastic tumor (IMFT) with and without ALK alterations: EORTC phase II study 90101 ``CREATE''

Affiliation auteurs!!!! Error affiliation !!!!
TitreProspective precision medicine trial of crizotinib (C) in patients (pts) with advanced, inoperable inflammatory myofibroblastic tumor (IMFT) with and without ALK alterations: EORTC phase II study 90101 ``CREATE''
Type de publicationJournal Article
Year of Publication2018
AuteursSchoffski P, Sufliarsky J, Gelderblom H, Blay J-Y, Strauss SJ, Stacchiotti S, Rutkowski P, Lindner LH, Leahy MG, Italiano A, Isambert N, Debiec-Rychter M, Sciot R, Van Cann T, Marreaud S, Nzokirantevye A, Collette S, Wozniak A
JournalCANCER RESEARCH
Volume78
Date PublishedJUL
Type of ArticleMeeting Abstract
ISSN0008-5472
DOI10.1158/1538-7445.AM2018-CT045